Jul 21, 2021

A16Z Leads Vitally Series A

A16Z Leads Vitally Series A

Alex Iskold

Read the coverage on TechCrunch.

Subscribe to our newsletter

Signup to get blog posts with our investments, theses and important announcements from 2048 Ventures.

Subscribe

Recent posts

Browse all articles
Theses
Jul 16, 2025

Our Thesis on Molecular Biosensors

We see two inevitabilities: the rise of biosensors in clinical trials to enable real-world endpoints, and the shift toward non-invasive, continuous monitoring that decentralizes care and replaces traditional lab tests.

Read more
Investments
Jul 9, 2025

Our Investment in Kascaid

Kascaid is building an interstitial fluid biosensor for immune monitoring starting in clinical trials, where more convenient and frequent sampling can reduce dropout and richer data can enable smaller, faster studies.

Read more
Investments
Jun 13, 2025

Our Investment in Nimbus Health

Nimbus Health is building the future of pulmonology.

Read more
Browse all articles

We back visionary founders who are building technologies of the future.

Get the newsletter with our latest investments and theses.
Subscribe

Copyright © 2025 | 2048 Ventures | Dots and Dashes by Morse